These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|||
|
(State or Other Jurisdiction
of Incorporation)
|
(IRS Employer
Identification No.)
|
|||
|
|
|
|||
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol
|
Name of each exchange
on which registered
|
||
|
Class A Common Stock, $0.001 par value per
share
|
|
|
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
Emerging growth company
|
|
|
Year Ended December 31,
|
||||||
|
(in thousands, except percentages and per share data)
|
2024
|
2023
|
2022
|
|||
|
Revenue
|
||||||
|
Net commissions and fees
|
$
2,455,671
|
$
2,026,596
|
$
1,711,861
|
|||
|
Fiduciary investment income
|
60,039
|
50,953
|
13,332
|
|||
|
Total revenue
|
$
2,515,710
|
$
2,077,549
|
$
1,725,193
|
|||
|
Expenses
|
||||||
|
Compensation and benefits
|
1,591,077
|
1,321,029
|
1,128,981
|
|||
|
General and administrative
|
352,050
|
276,181
|
196,971
|
|||
|
Amortization
|
157,845
|
106,799
|
103,601
|
|||
|
Depreciation
|
9,785
|
9,038
|
5,690
|
|||
|
Change in contingent consideration
|
(22,859)
|
5,421
|
442
|
|||
|
Total operating expenses
|
$
2,087,898
|
$
1,718,468
|
$
1,435,685
|
|||
|
Operating income
|
$
427,812
|
$
359,081
|
$
289,508
|
|||
|
Interest expense, net
|
158,448
|
119,507
|
104,829
|
|||
|
Loss (income) from equity method investment in related party
|
(18,231)
|
(8,731)
|
414
|
|||
|
Other non-operating loss
|
15,041
|
10,380
|
5,073
|
|||
|
Income before income taxes
|
$
272,554
|
$
237,925
|
$
179,192
|
|||
|
Income tax expense
|
42,641
|
43,445
|
15,935
|
|||
|
Net income
|
$
229,913
|
$
194,480
|
$
163,257
|
|||
|
GAAP financial measures
|
||||||
|
Revenue
|
$
2,515,710
|
$
2,077,549
|
$
1,725,193
|
|||
|
Compensation and benefits
|
1,591,077
|
1,321,029
|
1,128,981
|
|||
|
General and administrative
|
352,050
|
276,181
|
196,971
|
|||
|
Net income
|
229,913
|
194,480
|
163,257
|
|||
|
Total revenue growth rate
|
21.1
%
|
20.4
%
|
20.4
%
|
|||
|
Compensation and benefits expense ratio (1)
|
63.2
%
|
63.6
%
|
65.4
%
|
|||
|
General and administrative expense ratio (2)
|
14.0
%
|
13.3
%
|
11.4
%
|
|||
|
Net income margin (3)
|
9.1
%
|
9.4
%
|
9.5
%
|
|||
|
Earnings per share (4)
|
$
0.78
|
$
0.53
|
$
0.57
|
|||
|
Diluted earnings per share (4)
|
$
0.71
|
$
0.52
|
$
0.52
|
|||
|
Non-GAAP financial measures*
|
||||||
|
Organic revenue growth rate
|
12.8
%
|
15.4
%
|
16.8
%
|
|||
|
Adjusted compensation and benefits expense
|
$
1,426,674
|
$
1,222,342
|
$
1,021,823
|
|||
|
Adjusted compensation and benefits expense ratio
|
56.7
%
|
58.8
%
|
59.2
%
|
|||
|
Adjusted general and administrative expense
|
$
277,813
|
$
230,467
|
$
185,956
|
|||
|
Adjusted general and administrative expense ratio
|
11.0
%
|
11.1
%
|
10.8
%
|
|||
|
Adjusted EBITDAC
|
$
811,223
|
$
624,740
|
$
517,414
|
|||
|
Adjusted EBITDAC margin
|
32.2
%
|
30.1
%
|
30.0
%
|
|||
|
Adjusted net income
|
$
493,521
|
$
375,582
|
$
311,991
|
|||
|
Adjusted net income margin
|
19.6
%
|
18.1
%
|
18.1
%
|
|||
|
Adjusted diluted earnings per share
|
$
1.79
|
$
1.38
|
$
1.15
|
|||
|
Year Ended December 31,
|
Period over Period
|
|||||||||||
|
(in thousands, except
percentages)
|
2024
|
% of
total
|
2023
|
% of
total
|
Change
|
|||||||
|
Wholesale Brokerage
|
$
1,489,077
|
60.6
%
|
$
1,319,056
|
65.1
%
|
$
170,021
|
12.9
%
|
||||||
|
Binding Authority
|
320,379
|
13.0
|
275,961
|
13.6
|
44,418
|
16.1
|
||||||
|
Underwriting Management
|
646,215
|
26.3
|
431,579
|
21.3
|
214,636
|
49.7
|
||||||
|
Total Net commissions
and fees
|
$
2,455,671
|
$
2,026,596
|
$
429,075
|
21.2
%
|
||||||||
|
Year Ended December 31,
|
Period over Period
|
|||||||||||
|
(in thousands, except
percentages)
|
2024
|
% of
total
|
2023
|
% of
total
|
Change
|
|||||||
|
Net commissions and
policy fees
|
$
2,310,384
|
94.1
%
|
$
1,935,851
|
95.5
%
|
$
374,533
|
19.3
%
|
||||||
|
Supplemental and
contingent commissions
|
88,842
|
3.6
|
56,375
|
2.8
|
32,467
|
57.6
|
||||||
|
Loss mitigation and other
fees
|
56,445
|
2.3
|
34,370
|
1.7
|
22,075
|
64.2
|
||||||
|
Total Net commissions
and fees
|
$
2,455,671
|
$
2,026,596
|
$
429,075
|
21.2
%
|
||||||||
|
Year Ended December 31,
|
Period over Period
|
|||||||||||
|
(in thousands, except
percentages)
|
2023
|
% of
total
|
2022
|
% of
total
|
Change
|
|||||||
|
Wholesale Brokerage
|
$
1,319,056
|
65.1
%
|
$
1,129,241
|
66.0
%
|
$
189,815
|
16.8
%
|
||||||
|
Binding Authority
|
275,961
|
13.6
|
231,048
|
13.5
|
44,913
|
19.4
|
||||||
|
Underwriting Management
|
431,579
|
21.3
|
351,572
|
20.5
|
80,007
|
22.8
|
||||||
|
Total Net commissions
and fees
|
$
2,026,596
|
$
1,711,861
|
$
314,735
|
18.4
%
|
||||||||
|
Year Ended December 31,
|
Period over Period
|
|||||||||||
|
(in thousands, except
percentages)
|
2023
|
% of
total
|
2022
|
% of
total
|
Change
|
|||||||
|
Net commissions and
policy fees
|
$
1,935,851
|
95.5
%
|
$
1,633,325
|
95.4
%
|
$
302,526
|
18.5
%
|
||||||
|
Supplemental and
contingent commissions
|
56,375
|
2.8
|
50,005
|
2.9
|
6,370
|
12.7
|
||||||
|
Loss mitigation and other
fees
|
34,370
|
1.7
|
28,531
|
1.7
|
5,839
|
20.5
|
||||||
|
Total Net commissions
and fees
|
$
2,026,596
|
$
1,711,861
|
$
314,735
|
18.4
%
|
||||||||
|
Year Ended December 31,
|
|||||
|
(in thousands, except percentages)
|
2024
|
2023
|
2022
|
||
|
Current period Net commissions and fees revenue
|
$
2,455,671
|
$
2,026,596
|
$
1,711,861
|
||
|
Less: Current period contingent commissions
|
(73,175)
|
(39,028)
|
(30,788)
|
||
|
Net Commissions and fees revenue
excluding contingent commissions
|
$
2,382,496
|
$
1,987,568
|
$
1,681,073
|
||
|
Prior period Net commissions and fees revenue
|
$
2,026,596
|
$
1,711,861
|
$
1,432,179
|
||
|
Less: Prior period contingent commissions
|
(39,028)
|
(30,788)
|
(22,995)
|
||
|
Prior period Net commissions and fees revenue
excluding contingent commissions
|
$
1,987,568
|
$
1,681,073
|
$
1,409,184
|
||
|
Change in Net commissions and fees revenue excluding
contingent commissions
|
$
394,928
|
$
306,494
|
$
271,890
|
||
|
Less: Mergers and acquisitions Net commissions and fees
revenue excluding contingent commissions
|
(141,972)
|
(46,496)
|
(39,992)
|
||
|
Impact of change in foreign exchange rates
|
(791)
|
(479)
|
4,561
|
||
|
Organic revenue growth (Non-GAAP)
|
$
252,165
|
$
259,519
|
$
236,459
|
||
|
Net commissions and fees revenue growth rate (GAAP)
|
21.2 %
|
18.4 %
|
19.5 %
|
||
|
Less: Impact of contingent commissions (1)
|
(1.3)
|
(0.2)
|
(0.2)
|
||
|
Net commissions and fees revenue
excluding contingent commissions growth rate (2)
|
19.9 %
|
18.2 %
|
19.3 %
|
||
|
Less: Mergers and acquisitions Net commissions and fees
revenue excluding contingent commissions (3)
|
(7.1)
|
(2.8)
|
(2.8)
|
||
|
Impact of change in foreign exchange rates (4)
|
0.0
|
0.0
|
0.3
|
||
|
Organic Revenue Growth Rate (Non-GAAP)
|
12.8 %
|
15.4 %
|
16.8 %
|
||
|
Year Ended December 31,
|
||||||
|
(in thousands, except percentages)
|
2024
|
2023
|
2022
|
|||
|
Total Revenue
|
$
2,515,710
|
$
2,077,549
|
$
1,725,193
|
|||
|
Compensation and Benefits Expense
|
$
1,591,077
|
$
1,321,029
|
$
1,128,981
|
|||
|
Acquisition-related expense
|
(15,373)
|
(4,186)
|
(122)
|
|||
|
Acquisition related long-term incentive compensation (1)
|
(24,946)
|
4,334
|
(22,093)
|
|||
|
Restructuring and related expense
|
(39,929)
|
(22,651)
|
(724)
|
|||
|
Amortization and expense related to discontinued prepaid
incentives
|
(5,160)
|
(6,441)
|
(6,738)
|
|||
|
Equity-based compensation
|
(52,038)
|
(31,047)
|
(23,390)
|
|||
|
IPO related expenses
|
(26,957)
|
(38,696)
|
(54,091)
|
|||
|
Adjusted Compensation and Benefits Expense (2)
|
$
1,426,674
|
$
1,222,342
|
$
1,021,823
|
|||
|
Compensation and Benefits Expense Ratio
|
63.2%
|
63.6%
|
65.4%
|
|||
|
Adjusted Compensation and Benefits Expense Ratio
|
56.7%
|
58.8%
|
59.2%
|
|||
|
Year Ended December 31,
|
||||||
|
(in thousands, except percentages)
|
2024
|
2023
|
2022
|
|||
|
Total Revenue
|
$
2,515,710
|
$
2,077,549
|
$
1,725,193
|
|||
|
General and Administrative Expense
|
$
352,050
|
$
276,181
|
$
196,971
|
|||
|
Acquisition-related expense
|
(54,469)
|
(19,088)
|
(4,477)
|
|||
|
Restructuring and related expense
|
(19,768)
|
(26,626)
|
(4,993)
|
|||
|
IPO related expenses
|
—
|
—
|
(1,545)
|
|||
|
Adjusted General and Administrative Expense (1)
|
$
277,813
|
$
230,467
|
$
185,956
|
|||
|
General and Administrative Expense Ratio
|
14.0%
|
13.3%
|
11.4%
|
|||
|
Adjusted General and Administrative Expense Ratio
|
11.0%
|
11.1%
|
10.8%
|
|||
|
Year Ended December 31,
|
||||||
|
(in thousands, except percentages)
|
2024
|
2023
|
2022
|
|||
|
Total Revenue
|
$
2,515,710
|
$
2,077,549
|
$
1,725,193
|
|||
|
Net Income
|
$
229,913
|
$
194,480
|
$
163,257
|
|||
|
Interest expense, net
|
158,448
|
119,507
|
104,829
|
|||
|
Income tax expense
|
42,641
|
43,445
|
15,935
|
|||
|
Depreciation
|
9,785
|
9,038
|
5,690
|
|||
|
Amortization
|
157,845
|
106,799
|
103,601
|
|||
|
Change in contingent consideration (1)
|
(22,859)
|
5,421
|
442
|
|||
|
EBITDAC
|
$
575,773
|
$
478,690
|
$
393,754
|
|||
|
Acquisition-related expense
|
69,842
|
23,274
|
4,599
|
|||
|
Acquisition related long-term incentive compensation (2)
|
24,946
|
(4,334)
|
22,093
|
|||
|
Restructuring and related expense
|
59,697
|
49,277
|
5,717
|
|||
|
Amortization and expense related to discontinued prepaid incentives
|
5,160
|
6,441
|
6,738
|
|||
|
Other non-operating loss
|
15,041
|
10,380
|
5,073
|
|||
|
Equity-based compensation
|
52,038
|
31,047
|
23,390
|
|||
|
IPO related expenses
|
26,957
|
38,696
|
55,636
|
|||
|
Loss (income) from equity method investments in related party
|
(18,231)
|
(8,731)
|
414
|
|||
|
Adjusted EBITDAC
|
$
811,223
|
$
624,740
|
$
517,414
|
|||
|
Net Income Margin
|
9.1%
|
9.4%
|
9.5%
|
|||
|
Adjusted EBITDAC Margin
|
32.2%
|
30.1%
|
30.0%
|
|||
|
Year Ended December 31,
|
||||||
|
(in thousands, except percentages)
|
2024
|
2023
|
2022
|
|||
|
Total Revenue
|
$
2,515,710
|
$
2,077,549
|
$
1,725,193
|
|||
|
Net Income
|
$
229,913
|
$
194,480
|
$
163,257
|
|||
|
Income tax expense
|
42,641
|
43,445
|
15,935
|
|||
|
Amortization
|
157,845
|
106,799
|
103,601
|
|||
|
Amortization of deferred debt issuance costs (1)
|
23,930
|
12,172
|
12,054
|
|||
|
Change in contingent consideration
|
(22,859)
|
5,421
|
442
|
|||
|
Acquisition-related expense
|
69,842
|
23,274
|
4,599
|
|||
|
Acquisition related long-term incentive compensation
|
24,946
|
(4,334)
|
22,093
|
|||
|
Restructuring and related expense
|
59,697
|
49,277
|
5,717
|
|||
|
Amortization and expense related to discontinued prepaid incentives
|
5,160
|
6,441
|
6,738
|
|||
|
Other non-operating loss
|
15,041
|
10,380
|
5,073
|
|||
|
Equity-based compensation
|
52,038
|
31,047
|
23,390
|
|||
|
IPO related expenses
|
26,957
|
38,696
|
55,636
|
|||
|
Loss (income) loss from equity method investments in related party
|
(18,231)
|
(8,731)
|
414
|
|||
|
Adjusted Income before Income Taxes (2)
|
$
666,920
|
$
508,367
|
$
418,949
|
|||
|
Adjusted tax expense (3)
|
(173,399)
|
(132,785)
|
(106,958)
|
|||
|
Adjusted Net Income
|
$
493,521
|
$
375,582
|
$
311,991
|
|||
|
Net Income Margin
|
9.1%
|
9.4%
|
9.5%
|
|||
|
Adjusted Net Income Margin
|
19.6%
|
18.1%
|
18.1%
|
|||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Earnings per share of Class A common stock – diluted
|
$
0.71
|
$
0.52
|
$
0.52
|
|||
|
Less: Net income attributed to dilutive shares and substantively vested
RSUs (1)
|
—
|
(0.03)
|
(0.29)
|
|||
|
Plus: Impact of all LLC Common Units exchanged for Class A shares
(2)
|
0.14
|
0.24
|
0.38
|
|||
|
Plus: Adjustments to Adjusted net income (3)
|
0.97
|
0.67
|
0.56
|
|||
|
Plus: Dilutive impact of unvested equity awards (4)
|
(0.03)
|
(0.02)
|
(0.02)
|
|||
|
Adjusted diluted earnings per share
|
$
1.79
|
$
1.38
|
$
1.15
|
|||
|
(Share count in ’000s)
|
||||||
|
Weighted-average shares of Class A common stock outstanding –
diluted
|
132,891
|
125,745
|
265,750
|
|||
|
Plus: Impact of all LLC Common Units exchanged for Class A shares
(2)
|
138,980
|
142,384
|
—
|
|||
|
Plus: Dilutive impact of unvested equity awards (4)
|
4,417
|
4,137
|
4,731
|
|||
|
Adjusted diluted earnings per share diluted share count
|
276,288
|
272,266
|
270,481
|
|||
|
(in thousands)
|
Exchange Tax
Attributes
|
Pre-IPO M&A
Tax Attributes
|
TRA Payment
Tax Attributes
|
TRA
Liabilities
|
||||
|
Balance at December 31, 2023
|
$
194,668
|
$
85,814
|
$
78,416
|
$
358,898
|
||||
|
Exchange of LLC Common Units
|
73,433
|
5,660
|
21,982
|
101,075
|
||||
|
Remeasurement – change in state rate
|
(932)
|
(391)
|
(1,183)
|
(2,506)
|
||||
|
Remeasurement – foreign tax credits
|
(895)
|
—
|
—
|
(895)
|
||||
|
Interest expense
|
—
|
—
|
1,302
|
1,302
|
||||
|
Payments
|
(13,041)
|
(7,668)
|
(869)
|
(21,578)
|
||||
|
Balance at December 31, 2024
|
$
253,233
|
$
83,415
|
$
99,648
|
$
436,296
|
|
Long-term Incentive Compensation Agreements
|
||
|
(in thousands)
|
December 31, 2024
|
|
|
Current accrued compensation
|
$
11,055
|
|
|
Non-current accrued compensation
|
11,854
|
|
|
Total liability
|
$
22,909
|
|
|
Projected future expense
|
7,757
|
|
|
Total projected future cash outflows
|
$
30,666
|
|
|
Projected Future Cash Outflows
|
||
|
(in thousands)
|
||
|
2025
|
$
13,763
|
|
|
2026
|
6,053
|
|
|
2027
|
10,698
|
|
|
2028
|
51
|
|
|
Thereafter
|
$
101
|
|
|
Contingent Consideration
|
||
|
(in thousands)
|
December 31, 2024
|
|
|
Current accounts payable and accrued liabilities
|
$
48,164
|
|
|
Other non-current liabilities
|
80,895
|
|
|
Total liability
|
$
129,059
|
|
|
Projected future expense
|
13,115
|
|
|
Total projected future cash outflows
|
$
142,174
|
|
|
Projected Future Cash Outflows
|
||
|
(in thousands)
|
||
|
2025
|
$
48,945
|
|
|
2026
|
416
|
|
|
2027
|
92,813
|
|
|
2028
|
—
|
|
|
Thereafter
|
$
—
|
|
|
(in thousands)
|
Balance at
December 31, 2024
|
100 BPS
Increase
|
100 BPS
Decrease
|
||
|
Cash and cash equivalents
|
$
540,203
|
$
(5,402)
|
$
5,402
|
||
|
Term Loan principal outstanding (1)
|
1,700,000
|
17,000
|
$
(17,000)
|
||
|
Interest rate cap notional amount (2)
|
1,000,000
|
(10,000)
|
$
10,000
|
||
|
Net exposure to Interest expense, net
|
1,598
|
(1,598)
|
|||
|
Cash and cash equivalents held in a fiduciary capacity
|
1,140,602
|
11,406
|
$
(11,406)
|
||
|
Net exposure to Fiduciary investment income
|
$
11,406
|
$
(11,406)
|
|||
|
Impact to Net income
|
$
9,808
|
$
(9,808)
|
|
|
|
|
Consolidated Statements of Comprehensive Income for the years ended
December 31, 2024
,
2023
, and
2022
|
|
|
|
|
|
|
|
|
Consolidated Statements of Stockholders’ Equity for the years ended
December 31, 2024
,
2023
, and
2022
|
|
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
REVENUE
|
||||||
|
Net commissions and fees
|
$
|
$
|
$
|
|||
|
Fiduciary investment income
|
|
|
|
|||
|
Total revenue
|
$
|
$
|
$
|
|||
|
EXPENSES
|
||||||
|
Compensation and benefits
|
|
|
|
|||
|
General and administrative
|
|
|
|
|||
|
Amortization
|
|
|
|
|||
|
Depreciation
|
|
|
|
|||
|
Change in contingent consideration
|
(
|
|
|
|||
|
Total operating expenses
|
$
|
$
|
$
|
|||
|
OPERATING INCOME
|
$
|
$
|
$
|
|||
|
Interest expense, net
|
|
|
|
|||
|
Loss (income) from equity method investment in related party
|
(
|
(
|
|
|||
|
Other non-operating loss
|
|
|
|
|||
|
INCOME BEFORE INCOME TAXES
|
$
|
$
|
$
|
|||
|
Income tax expense
|
|
|
|
|||
|
NET INCOME
|
$
|
$
|
$
|
|||
|
Net income attributable to non-controlling interests, net of tax
|
|
|
|
|||
|
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY
HOLDINGS, INC.
|
$
|
$
|
$
|
|||
|
NET INCOME PER SHARE OF CLASS A COMMON
STOCK:
|
||||||
|
Basic
|
$
|
$
|
$
|
|||
|
Diluted
|
$
|
$
|
$
|
|||
|
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON
STOCK OUTSTANDING:
|
||||||
|
Basic
|
|
|
|
|||
|
Diluted
|
|
|
|
|||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
NET INCOME
|
$
|
$
|
$
|
|||
|
Net income attributable to non-controlling interests, net of tax
|
|
|
|
|||
|
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY
HOLDINGS, INC.
|
$
|
$
|
$
|
|||
|
Other comprehensive income (loss), net of tax:
|
||||||
|
Gain on interest rate cap
|
|
|
|
|||
|
(Gain) on interest rate cap reclassified to earnings
|
(
|
(
|
(
|
|||
|
Foreign currency translation adjustments
|
(
|
|
(
|
|||
|
Change in share of equity method investment in related party
other comprehensive income (loss)
|
|
(
|
(
|
|||
|
Total other comprehensive income (loss), net of tax
|
$
(
|
$
(
|
$
|
|||
|
COMPREHENSIVE INCOME ATTRIBUTABLE TO RYAN
SPECIALTY HOLDINGS, INC.
|
$
|
$
|
$
|
|||
|
December 31, 2024
|
December 31, 2023
|
|||
|
ASSETS
|
||||
|
CURRENT ASSETS
|
||||
|
Cash and cash equivalents
|
$
|
$
|
||
|
Commissions and fees receivable – net
|
|
|
||
|
Fiduciary cash and receivables
|
|
|
||
|
Prepaid incentives – net
|
|
|
||
|
Other current assets
|
|
|
||
|
Total current assets
|
$
|
$
|
||
|
NON-CURRENT ASSETS
|
||||
|
Goodwill
|
|
|
||
|
Customer relationships
|
|
|
||
|
Other intangible assets
|
|
|
||
|
Prepaid incentives – net
|
|
|
||
|
Equity method investment in related party
|
|
|
||
|
Property and equipment – net
|
|
|
||
|
Lease right-of-use assets
|
|
|
||
|
Deferred tax assets
|
|
|
||
|
Other non-current assets
|
|
|
||
|
Total non-current assets
|
$
|
$
|
||
|
TOTAL ASSETS
|
$
|
$
|
||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||
|
CURRENT LIABILITIES
|
||||
|
Accounts payable and accrued liabilities
|
$
|
$
|
||
|
Accrued compensation
|
|
|
||
|
Operating lease liabilities
|
|
|
||
|
Short-term debt and current portion of long-term debt
|
|
|
||
|
Fiduciary liabilities
|
|
|
||
|
Total current liabilities
|
$
|
$
|
||
|
NON-CURRENT LIABILITIES
|
||||
|
Accrued compensation
|
|
|
||
|
Operating lease liabilities
|
|
|
||
|
Long-term debt
|
|
|
||
|
Tax Receivable Agreement liabilities
|
|
|
||
|
Deferred tax liabilities
|
|
|
||
|
Other non-current liabilities
|
|
|
||
|
Total non-current liabilities
|
$
|
$
|
||
|
TOTAL LIABILITIES
|
$
|
$
|
||
|
STOCKHOLDERS’ EQUITY
|
||||
|
Class A common stock (
$
shares issued and outstanding at
December 31, 2024
and
2023
, respectively)
|
|
|
||
|
Class B common stock (
$
shares issued and outstanding at
December 31, 2024
and
2023
, respectively)
|
|
|
||
|
Class X common stock (
$
outstanding at
December 31, 2024
and
2023
)
|
|
|
||
|
Preferred stock (
$
December 31, 2024
and
2023
)
|
|
|
||
|
Additional paid-in capital
|
|
|
||
|
Retained earnings
|
|
|
||
|
Accumulated other comprehensive income (loss)
|
(
|
|
||
|
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc.
|
$
|
$
|
||
|
Non-controlling interests
|
|
|
||
|
Total stockholders’ equity
|
$
|
$
|
||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
$
|
|
Year Ended December 31,
|
|||||
|
2024
|
2023
|
2022
|
|||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|||||
|
Net income
|
$
|
$
|
$
|
||
|
Adjustments to reconcile net income to cash flows provided by operating activities:
|
|||||
|
Loss (income) from equity method investment in related party
|
(
|
(
|
|
||
|
Amortization
|
|
|
|
||
|
Depreciation
|
|
|
|
||
|
Prepaid and deferred compensation expense
|
|
|
|
||
|
Non-cash equity-based compensation
|
|
|
|
||
|
Amortization of deferred debt issuance costs
|
|
|
|
||
|
Amortization of interest rate cap premium
|
|
|
|
||
|
Deferred income tax expense
|
|
|
|
||
|
Deferred income tax expense from common control reorganizations
|
|
|
|
||
|
(Gain) loss on Tax Receivable Agreement
|
(
|
|
|
||
|
Changes in operating assets and liabilities, net of acquisitions:
|
|||||
|
Commissions and fees receivable – net
|
(
|
(
|
(
|
||
|
Accrued interest liability
|
|
|
|
||
|
Other current and non-current assets
|
(
|
|
(
|
||
|
Other current and non-current liabilities
|
(
|
|
(
|
||
|
Total cash flows provided by operating activities
|
$
|
$
|
$
|
||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|||||
|
Business combinations – net of cash acquired and cash held in a fiduciary capacity
|
(
|
(
|
|
||
|
Capital expenditures
|
(
|
(
|
(
|
||
|
Asset acquisitions
|
|
|
(
|
||
|
Repayments of prepaid incentives
|
|
|
|
||
|
Total cash flows used in investing activities
|
$
(
|
$
(
|
$
(
|
||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|||||
|
Proceeds from Senior Secured Notes
|
|
|
|
||
|
Borrowings on Revolving Credit Facility
|
|
|
|
||
|
Repayments on Revolving Credit Facility
|
(
|
|
|
||
|
Debt issuance costs paid
|
(
|
|
(
|
||
|
Proceeds from term debt
|
|
|
|
||
|
Repayment of term debt
|
(
|
(
|
(
|
||
|
Payment of interest rate cap premium, net
|
|
|
(
|
||
|
Payment of contingent consideration
|
|
(
|
(
|
||
|
Tax distributions to non-controlling LLC Unitholders
|
(
|
(
|
(
|
||
|
Receipt of taxes related to net share settlement of equity awards
|
|
|
|
||
|
Taxes paid related to net share settlement of equity awards
|
(
|
(
|
(
|
||
|
Payment of Tax Receivable Agreement liabilities
|
(
|
(
|
(
|
||
|
Dividends paid to Class A common shareholders
|
(
|
|
|
||
|
Distributions to non-controlling LLC Unitholders
|
(
|
|
|
||
|
Payment of accrued return on Ryan Re preferred units
|
(
|
|
|
||
|
Finance lease and other costs paid
|
|
|
(
|
||
|
Net change in fiduciary liabilities
|
|
|
|
||
|
Total cash flows provided by (used in) financing activities
|
$
|
$
(
|
$
|
||
|
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and
cash equivalents held in a fiduciary capacity
|
(
|
|
(
|
||
|
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH
EQUIVALENTS HELD IN A FIDUCIARY CAPACITY
|
$
(
|
$
(
|
$
|
||
|
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD
IN A FIDUCIARY CAPACITY—Beginning balance
|
|
|
|
||
|
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD
IN A FIDUCIARY CAPACITY—Ending balance
|
$
|
$
|
$
|
||
|
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a
fiduciary capacity
|
|||||
|
Cash and cash equivalents
|
$
|
$
|
$
|
||
|
Cash and cash equivalents held in a fiduciary capacity
|
|
|
|
||
|
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary
capacity
|
$
|
$
|
$
|
||
|
Class A
Common Stock
|
Class B
Common Stock
|
|||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Retained
Earnings
(Accumulated
Deficit)
|
Accumulated
Other
Comprehensive
Income
|
Non-
controlling
Interests
|
Total
Stockholders’
Equity
|
||||||||||
|
Balance at December 31, 2021
|
|
$
|
|
$
|
$
|
$
(
|
$
|
$
|
$
|
|||||||||
|
Net income
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|
|||||||||
|
Issuance of common stock
|
|
|
|
—
|
|
—
|
—
|
—
|
|
|||||||||
|
Exchange of LLC equity for common stock
|
|
|
(
|
(
|
|
—
|
—
|
(
|
|
|||||||||
|
Forfeiture of common stock
|
(
|
(
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
|||||||||
|
Tax Receivable Agreement liability and
deferred taxes arising from LLC interest
ownership changes
|
—
|
—
|
—
|
—
|
(
|
—
|
—
|
—
|
(
|
|||||||||
|
Distributions declared for non-controlling
interest holders’ tax
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
Change in share of equity method investment
in related party other comprehensive loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||
|
Gain on interest rate cap, net
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|||||||||
|
Foreign currency translation adjustments
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||
|
Equity-based compensation
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
|
|||||||||
|
Balance at December 31, 2022
|
|
$
|
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||||
|
Net income
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|
|||||||||
|
Issuance of common stock
|
|
|
|
|
|
—
|
—
|
|
|
|||||||||
|
Forfeiture and retirement of common stock
|
(
|
—
|
—
|
—
|
|
(
|
—
|
—
|
(
|
|||||||||
|
Exchange of LLC equity for common stock
|
|
|
(
|
(
|
|
—
|
—
|
(
|
|
|||||||||
|
Equity awards withheld for settlement of
employee tax obligations
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
Tax Receivable Agreement liability and
deferred taxes arising from LLC interest
ownership changes
|
—
|
—
|
—
|
—
|
(
|
—
|
—
|
|
(
|
|||||||||
|
Distributions declared for non-controlling
interest holders’ tax
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
Change in share of equity method investment
in related party other comprehensive loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||
|
Loss on interest rate cap, net
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||
|
Foreign currency translation adjustments
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|||||||||
|
Equity-based compensation
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
|
|||||||||
|
Balance at December 31, 2023
|
|
$
|
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||||
|
Class A
Common Stock
|
Class B
Common Stock
|
|||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Non-
controlling
Interests
|
Total
Stockholders’
Equity
|
||||||||||
|
Balance at December 31, 2023
|
|
$
|
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||||
|
Net income
|
—
|
—
|
—
|
—
|
—
|
|
—
|
|
|
|||||||||
|
Issuance of common stock
|
|
|
|
—
|
|
—
|
—
|
|
|
|||||||||
|
Forfeiture and retirement of common stock
|
(
|
—
|
—
|
—
|
|
(
|
—
|
—
|
(
|
|||||||||
|
Exchange of LLC equity for common stock
|
|
|
(
|
(
|
|
—
|
—
|
(
|
|
|||||||||
|
Equity awards withheld for settlement of
employee tax obligations
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
Class A common stock dividends and
Dividend Equivalents
|
—
|
—
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
|||||||||
|
Distributions and Declared Distributions to
non-controlling LLC Unitholders
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
Tax Receivable Agreement liability and
deferred taxes arising from LLC interest
ownership changes
|
—
|
—
|
—
|
—
|
(
|
—
|
—
|
|
|
|||||||||
|
Distributions declared for non-controlling
interest holders’ tax
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
|||||||||
|
Change in share of equity method investment
in related party other comprehensive income
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|||||||||
|
Loss on interest rate cap, net
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||
|
Foreign currency translation adjustments
|
—
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
(
|
|||||||||
|
Equity-based compensation
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
|
|||||||||
|
Balance at December 31, 2024
|
|
$
|
|
$
|
$
|
$
|
$
(
|
$
|
$
|
|||||||||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Wholesale Brokerage
|
$
|
$
|
$
|
|||
|
Binding Authority
|
|
|
|
|||
|
Underwriting Management
|
|
|
|
|||
|
Total Net commissions and fees
|
$
|
$
|
$
|
|||
|
|
Castel
|
US Assure
|
Greenhill
|
Ethos P&C
|
EverSports
|
Innovisk
|
Total
|
|||||||
|
Cash and cash equivalents
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Commissions and fees receivable – net
|
|
|
|
|
|
|
|
|||||||
|
Fiduciary cash and receivables
|
|
|
|
|
|
|
|
|||||||
|
Goodwill
|
|
|
|
|
|
|
|
|||||||
|
Customer relationships
1
|
|
|
|
|
|
|
|
|||||||
|
Other intangible assets
|
|
|
|
|
|
|
|
|||||||
|
Lease right-of-use assets
|
|
|
|
|
|
|
|
|||||||
|
Other current and non-current assets
|
|
|
|
|
|
|
|
|||||||
|
Total assets acquired
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Accounts payable and accrued liabilities
|
|
|
|
|
|
|
|
|||||||
|
Accrued compensation
|
|
|
|
|
|
|
|
|||||||
|
Fiduciary liabilities
|
|
|
|
|
|
|
|
|||||||
|
Operating lease liabilities
|
|
|
|
|
|
|
|
|||||||
|
Deferred tax liabilities
|
|
|
|
|
|
|
|
|||||||
|
Total liabilities assumed
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Net assets acquired
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|
Year Ended December 31,
|
||||
|
2024
|
2023
|
|||
|
Total revenue
|
$
|
$
|
||
|
Net income
|
|
|
||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Change in contingent consideration
|
$
(
|
$
|
$
|
|||
|
Interest expense, net
|
|
|
|
|||
|
Total
|
$
(
|
$
|
$
|
|||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
Total
|
||||
|
Operations and technology optimization
|
$
|
$
|
$
|
|||
|
Compensation and benefits
|
|
|
|
|||
|
Asset impairment and other termination costs
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
|||
|
|
Operations and
Technology
Optimization
|
Compensation and
Benefits
|
Asset Impairment
and Other
Termination Costs
|
Total
|
||||
|
Balance at December 31, 2023
|
$
|
$
|
$
|
$
|
||||
|
Accrued costs
|
|
|
|
|
||||
|
Payments
|
(
|
(
|
|
(
|
||||
|
Non-cash adjustments
|
|
|
(
|
(
|
||||
|
Balance at December 31, 2024
|
$
|
$
|
$
|
$
|
|
Year Ended December 31,
|
||||
|
2024
|
2023
|
|||
|
Balance at beginning of period
|
$
|
$
|
||
|
Write-offs
|
(
|
(
|
||
|
Increase in provision
|
|
|
||
|
Balance at end of period
|
$
|
$
|
||
|
As of December 31,
|
||||
|
2024
|
2023
|
|||
|
Prepaid expenses
|
$
|
$
|
||
|
Insurance recoverable
|
|
|
||
|
Interest rate cap
|
|
|
||
|
Other current receivables
|
|
|
||
|
Total Other current assets
|
$
|
$
|
||
|
Goodwill
|
||
|
Balance at December 31, 2022
|
$
|
|
|
Acquisitions
|
|
|
|
Impact of exchange rate changes
|
|
|
|
Balance at December 31, 2023
|
$
|
|
|
Acquisitions
|
|
|
|
Measurement period adjustments
|
|
|
|
Impact of exchange rate changes
|
(
|
|
|
Balance at December 31, 2024
|
$
|
|
As of December 31, 2024
|
As of December 31, 2023
|
|||||||||||
|
Cost
|
Accumulated
Amortization
|
Net Carrying
Amount
|
Cost
|
Accumulated
Amortization
|
Net Carrying
Amount
|
|||||||
|
Customer
relationships
|
$
|
$
(
|
$
|
$
|
$
(
|
$
|
||||||
|
Trade names
|
|
(
|
|
|
(
|
|
||||||
|
Internally
developed
software
|
|
(
|
|
|
(
|
|
||||||
|
Total
|
$
|
$
(
|
$
|
$
|
$
(
|
$
|
||||||
|
Customer
Relationships
|
Trade Names
|
Internally Developed
Software
|
||||
|
2025
|
$
|
$
|
$
|
|||
|
2026
|
|
|
|
|||
|
2027
|
|
|
|
|||
|
2028
|
|
|
|
|||
|
2029
|
|
|
|
|||
|
Thereafter
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Lease costs
|
||||||
|
Operating lease costs
|
$
|
$
|
$
|
|||
|
Finance lease costs
|
|
|
|
|||
|
Short-term lease costs
|
||||||
|
Operating lease costs
|
|
|
|
|||
|
Finance lease costs
|
|
|
|
|||
|
Sublease income
|
(
|
(
|
(
|
|||
|
Lease costs – net
|
$
|
$
|
$
|
|||
|
Cash paid for amounts included in the measurement of lease
liabilities
|
||||||
|
Operating cash flows used for operating leases
|
$
|
$
|
$
|
|||
|
Non-cash related activities
|
||||||
|
Right-of-use assets obtained in exchange for new operating lease
liabilities
|
|
|
|
|||
|
Amortization of right-of-use assets for operating lease activity
|
|
|
|
|||
|
Weighted average discount rate (percent)
|
||||||
|
Operating leases
|
|
|
|
|||
|
Finance leases
|
|
|
|
|||
|
Weighted average remaining lease term (years)
|
||||||
|
Operating leases
|
|
|
|
|||
|
Finance leases
|
—
|
—
|
|
|||
|
2025
|
$
|
|
|
2026
|
|
|
|
2027
|
|
|
|
2028
|
|
|
|
2029
|
|
|
|
Thereafter
|
|
|
|
Total undiscounted future lease payments
|
$
|
|
|
Less: Imputed interest
|
(
|
|
|
Present value lease liabilities
|
$
|
|
|
As of December 31,
|
|||
|
|
2024
|
2023
|
||
|
Term debt
|
||||
|
Adjusted Term SOFR +
SOFR +
|
$
|
$
|
||
|
Senior secured notes
|
||||
|
|
|
|
||
|
August 1, 2032
|
|
|
||
|
Revolving debt
|
||||
|
SOFR + up to
to
matures
|
|
|
||
|
Premium financing notes
|
||||
|
Commercial notes, periodic interest and principal payments,
expire
|
|
|
||
|
Commercial notes, periodic interest and principal payments,
expire
|
|
|
||
|
Commercial notes, periodic interest and principal payments,
expire
|
|
|
||
|
Commercial notes, periodic interest and principal payments,
expired
|
|
|
||
|
Commercial notes, periodic interest and principal payments,
expired
|
|
|
||
|
Commercial notes, periodic interest and principal payments,
expired
|
|
|
||
|
Commercial notes, periodic interest and principal payments,
expired
|
|
|
||
|
Units subject to mandatory redemption
|
|
|
||
|
Total debt
|
$
|
$
|
||
|
Less: Short-term debt and current portion of long-term debt
|
(
|
(
|
||
|
Long-term debt
|
$
|
$
|
||
|
2025
|
$
|
|
|
2026
|
|
|
|
2027
|
|
|
|
2028
|
|
|
|
2029
|
|
|
|
Thereafter
|
|
|
|
Total repayments
|
$
|
|
|
Less: Unamortized discounts and debt issuance costs
|
(
|
|
|
Total
|
$
|
|
Year Ended December 31, 2024
|
||||||||
|
Restricted Stock
|
Weighted
Average Grant
Date Fair Value
|
Restricted
Common Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
|
Unvested at beginning of period
|
|
$
|
|
$
|
||||
|
Granted
|
|
|
|
|
||||
|
Vested
|
(
|
|
(
|
|
||||
|
Forfeited
|
(
|
|
|
|
||||
|
Unvested at end of period
|
|
$
|
|
$
|
||||
|
Year Ended December 31, 2024
|
||||||||
|
IPO RSUs
|
Incentive RSUs
|
|||||||
|
Restricted
Stock Units
|
Weighted
Average Grant
Date Fair Value
|
Restricted
Stock Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
|
Unvested at beginning of period
|
|
$
|
|
$
|
||||
|
Granted
|
|
|
|
|
||||
|
Vested
|
(
|
|
(
|
|
||||
|
Forfeited
|
(
|
|
(
|
|
||||
|
Unvested at end of period
|
|
$
|
|
$
|
||||
|
Year Ended December 31, 2024
|
|||||||||
|
Reload Options
1
|
Staking Options
1
|
Incentive
Options
|
Incentive Options
Weighted
Average Exercise
Price
|
||||||
|
Outstanding at beginning of period
|
|
|
|
$
|
|||||
|
Granted
|
|
|
|
|
|||||
|
Exercised
|
(
|
|
|
|
|||||
|
Forfeited
|
(
|
|
(
|
|
|||||
|
Outstanding at end of period
|
|
|
|
$
|
|||||
|
Year Ended December 31,
|
||||
|
2024
|
2022
|
|||
|
Volatility
|
|
|
||
|
Time to maturity (years)
|
|
|
||
|
Risk-free rate
|
|
|
||
|
Dividend yield
|
|
|
||
|
Fair value per option
|
$
|
$
|
||
|
Aggregate intrinsic value ($ in thousands):
|
|
|
|
Reload Options outstanding
|
$
|
|
|
Reload Options exercisable
|
|
|
|
Staking Options outstanding
|
|
|
|
Staking Options exercisable
|
|
|
|
Incentive Options outstanding
|
|
|
|
Incentive Options exercisable
|
|
|
|
Weighted-average remaining contractual term (in years):
|
|
|
|
Reload Options outstanding
|
|
|
|
Reload Options exercisable
|
|
|
|
Staking Options outstanding
|
|
|
|
Staking Options exercisable
|
|
|
|
Incentive Options outstanding
|
|
|
|
Incentive Options exercisable
|
—
|
|
Year Ended December 31, 2024
|
||||||||
|
IPO RLUs
|
Incentive RLUs
|
|||||||
|
Restricted
LLC Units
|
Weighted
Average Grant
Date Fair Value
|
Restricted
LLC Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
|
Unvested at beginning of period
|
|
$
|
|
$
|
||||
|
Granted
|
|
|
|
|
||||
|
Vested
|
(
|
|
(
|
|
||||
|
Forfeited
|
|
|
|
|
||||
|
Unvested at end of period
|
|
$
|
|
$
|
||||
|
Year Ended December 31, 2024
|
|||||||||
|
Reload Class C
Incentive Units
|
Staking Class C
Incentive Units
|
Class C
Incentive Units
|
Class C Incentive
Units Weighted
Average
Participation
Threshold
|
||||||
|
Unvested at beginning of period
|
|
|
|
$
|
|||||
|
Granted
|
|
|
|
|
|||||
|
Vested
|
(
|
(
|
|
|
|||||
|
Forfeited
|
|
|
|
|
|||||
|
Unvested at end of period
|
|
|
|
$
|
|||||
|
Year Ended December 31, 2024
|
||||||||
|
PSUs
|
PLUs
|
|||||||
|
Performance
Stock Units
|
Weighted
Average Grant
Date Fair Value
|
Performance
LLC Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
|
Unvested at beginning of period
|
|
$
|
|
$
|
||||
|
Granted
|
|
|
|
|
||||
|
Vested
|
|
|
|
|
||||
|
Forfeited
|
|
|
|
|
||||
|
Unvested at end of period
|
|
$
|
|
$
|
||||
|
PSUs and PLUs
|
||
|
Volatility
|
|
|
|
Time to maturity (years)
|
|
|
|
Risk-free rate
|
|
|
|
RYAN stock price at valuation date
|
$
|
|
Amount
|
Weighted Average
Remaining Expense
Period (Years)
|
|||
|
Restricted Stock
|
$
|
|
||
|
IPO RSUs
|
|
|
||
|
Incentive RSUs
|
|
|
||
|
Reload Options
|
|
|
||
|
Staking Options
|
|
|
||
|
Incentive Options
|
|
|
||
|
PSUs
|
|
|
||
|
Restricted Common Units
|
|
|
||
|
IPO RLUs
|
|
|
||
|
Incentive RLUs
|
|
|
||
|
Reload Class C Incentive Units
|
|
|
||
|
Staking Class C Incentive Units
|
|
|
||
|
Class C Incentive Units
|
|
|
||
|
PLUs
|
|
|
||
|
Total unrecognized equity-based compensation expense
|
$
|
|
Recognized
|
Unrecognized
|
|||||||
|
Year Ended December 31,
|
As of
|
|||||||
|
2024
|
2023
|
2022
|
December 31, 2024
|
|||||
|
IPO awards
|
||||||||
|
IPO RSUs and Staking Options
|
$
|
$
|
$
|
$
|
||||
|
IPO RLUs and Staking Class C Incentive Units
|
|
|
|
|
||||
|
Incremental Restricted Stock and Reload
Options
|
|
|
|
|
||||
|
Incremental Restricted Common Units and
Reload Class C Incentive Units
|
|
|
|
|
||||
|
Pre-IPO incentive awards
|
||||||||
|
Restricted Stock
|
|
|
|
|
||||
|
Restricted Common Units
|
|
|
|
|
||||
|
Post-IPO incentive awards
|
|
|
|
|
||||
|
Incentive RSUs
|
|
|
|
|
||||
|
Incentive RLUs
|
|
|
|
|
||||
|
Incentive Options
|
|
|
|
|
||||
|
Class C Incentive Units
|
|
|
|
|
||||
|
PSUs
|
|
|
|
|
||||
|
PLUs
|
|
|
|
|
||||
|
Other expense
|
||||||||
|
Director Stock Grants
|
|
|
|
|
||||
|
Profit sharing contribution
|
|
|
|
|
||||
|
Total equity-based compensation expense
|
$
|
$
|
$
|
$
|
||||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Net income
|
$
|
$
|
$
|
|||
|
Less: Net income attributable to non-controlling interests
|
|
|
|
|||
|
Net income attributable to Ryan Specialty Holdings, Inc.
|
$
|
$
|
$
|
|||
|
Numerator:
|
||||||
|
Net income attributable to Class A common shareholders
|
$
|
$
|
$
|
|||
|
Add (less): Income attributed to substantively vested RSUs
|
|
(
|
|
|||
|
Net income attributable to Class A common shareholders – basic
|
$
|
$
|
$
|
|||
|
Add: Income attributed to dilutive shares
|
|
|
|
|||
|
Net income attributable to Class A common shareholders – diluted
|
$
|
$
|
$
|
|||
|
Denominator:
|
||||||
|
Weighted-average shares of Class A common stock outstanding –
basic
|
|
|
|
|||
|
Add: Dilutive shares
|
|
|
|
|||
|
Weighted-average shares of Class A common stock outstanding –
diluted
|
|
|
|
|||
|
Earnings per share
|
||||||
|
Earnings per share of Class A common stock – basic
|
$
|
$
|
$
|
|||
|
Earnings per share of Class A common stock – diluted
|
$
|
$
|
$
|
|||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Conversion of non-controlling interest LLC Common Units
1
|
|
|
|
|||
|
Conversion of vested Class C Incentive Units
1
|
|
|
|
|||
|
Class C Incentive Units
|
|
|
|
|||
|
Incentive Options
|
|
|
|
|||
|
Year Ended December 31,
|
|||||||
|
Income Statement Caption
|
2024
|
2023
|
2022
|
||||
|
Change in the fair value of the Deal-
Contingent Forward
|
General and administrative
|
$
(
|
$
(
|
$
|
|||
|
Total impact of derivatives not designated as hedging instruments
|
$
(
|
$
(
|
$
|
||||
|
Interest rate cap premium amortization
|
Interest expense, net
|
$
(
|
$
(
|
$
(
|
|||
|
Amounts reclassified out of other
comprehensive income related to the
interest rate cap
|
Interest expense, net
|
|
|
|
|||
|
Total impact of derivatives designated as hedging instruments
|
$
|
$
|
$
(
|
||||
|
|
As of December 31,
|
||||
|
Balance Sheet Caption
|
2024
|
2023
|
|||
|
Derivatives not designated as hedging instruments
|
|||||
|
Deal-Contingent Forward
|
Accounts payable and
accrued liabilities
|
$
|
$
|
||
|
Derivatives designated as hedging instruments
|
|||||
|
Interest rate cap
|
Other current assets
|
$
|
$
|
||
|
Interest rate cap
|
Other non-current assets
|
$
|
$
|
||
|
|
As of December 31, 2024
|
As of December 31, 2023
|
||||||||||
|
|
Level 1
|
Level 2
|
Level 3
|
Level 1
|
Level 2
|
Level 3
|
||||||
|
Assets:
|
||||||||||||
|
Interest rate cap
|
$
|
$
|
$
|
$
|
$
|
$
|
||||||
|
Contingently returnable
consideration
|
|
|
|
|
|
|
||||||
|
Liabilities:
|
||||||||||||
|
Contingent consideration
|
|
|
|
|
|
|
||||||
|
Deal-Contingent Forward
|
|
|
|
|
|
|
||||||
|
Total assets and liabilities
measured at fair value
|
$
|
$
|
$
|
$
|
$
|
$
|
||||||
|
Year Ended December 31,
|
||||
|
2024
|
2023
|
|||
|
Assets
|
||||
|
Balance at beginning of period
|
$
|
$
|
||
|
Newly established assets due to acquisitions
|
|
|
||
|
|
|
|
||
|
|
(
|
|
||
|
Balance at end of period
|
$
|
$
|
||
|
Liabilities
|
||||
|
Balance at beginning of period
|
$
|
$
|
||
|
Newly established liabilities due to acquisitions
|
|
|
||
|
Newly established liability due to derivatives
|
|
|
||
|
|
(
|
|
||
|
Settlements
|
(
|
(
|
||
|
Acquisition measurement period adjustments
|
|
|
||
|
Balance at end of period
|
$
|
$
|
||
|
Year Ended December 31,
|
||||
|
2024
|
2023
|
|||
|
Balance at beginning of period
|
$
|
$
|
||
|
Income from equity method investment in related party
|
|
|
||
|
Change in share of equity method investment in related party other comprehensive
income (loss)
|
|
(
|
||
|
Balance at end of period
|
$
|
$
|
||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
United States
|
$
|
$
|
$
|
|||
|
Foreign
|
|
|
|
|||
|
Income before income taxes
|
$
|
$
|
$
|
|||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Current income tax expense
|
||||||
|
Federal
|
$
|
$
|
$
|
|||
|
State
|
|
|
|
|||
|
Foreign
|
|
|
|
|||
|
Current income tax expense
|
$
|
$
|
$
|
|||
|
Deferred income tax expense (benefit)
|
||||||
|
Federal
|
|
|
|
|||
|
State
|
|
(
|
(
|
|||
|
Foreign
|
(
|
(
|
|
|||
|
Deferred income tax expense
|
$
|
$
|
$
|
|||
|
Income tax expense
|
$
|
$
|
$
|
|||
|
Year Ended December 31,
|
||||||||||||
|
2024
|
2023
|
2022
|
||||||||||
|
Income taxes at U.S. federal statutory rate
|
$
|
|
$
|
|
$
|
|
||||||
|
Income attributable to non-controlling interests
and nontaxable income
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||
|
Nondeductible expenses
|
|
|
|
|
|
|
||||||
|
State and local taxes, net of federal benefit
|
|
|
|
|
|
|
||||||
|
Equity-based compensation
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||
|
Common Control Reorganizations
|
|
|
|
|
|
|
||||||
|
Foreign rate differential
|
|
|
|
|
|
|
||||||
|
Change in state rate
|
|
|
(
|
(
|
(
|
(
|
||||||
|
Change in valuation allowance
|
|
|
|
|
|
|
||||||
|
Other TRA related (income) loss
|
(
|
(
|
|
|
|
|
||||||
|
Other
|
|
|
|
|
(
|
(
|
||||||
|
Income tax expense
|
$
|
|
$
|
|
$
|
|
||||||
|
As of December 31,
|
||||
|
2024
|
2023
|
|||
|
Deferred tax assets
|
||||
|
Net operating losses
|
$
|
$
|
||
|
Investment in the LLC
|
|
|
||
|
Start-up costs
|
|
|
||
|
Equity-based compensation
|
|
|
||
|
Tax credits
|
|
|
||
|
Capitalized research and development
|
|
|
||
|
Other accrued items
|
|
|
||
|
Total deferred tax assets
|
$
|
$
|
||
|
Valuation allowances
|
(
|
(
|
||
|
Deferred tax assets, net of valuation allowance
|
$
|
$
|
||
|
Deferred tax liabilities
|
||||
|
Intangibles
|
(
|
(
|
||
|
Fixed assets
|
|
(
|
||
|
Other accrued items
|
|
(
|
||
|
Deferred tax liabilities
|
$
(
|
$
(
|
||
|
Net Deferred tax assets
|
$
|
$
|
||
|
|
Exchange Tax
Attributes
|
Pre-IPO M&A
Tax Attributes
|
TRA Payment
Tax Attributes
|
TRA
Liabilities
|
||||
|
Balance at December 31, 2022
|
$
|
$
|
$
|
$
|
||||
|
Exchange of LLC Common Units
|
|
|
|
|
||||
|
Remeasurement – change in state rate
|
|
|
|
|
||||
|
Interest expense
|
|
|
|
|
||||
|
Payments
|
(
|
(
|
(
|
(
|
||||
|
Balance at December 31, 2023
|
$
|
$
|
$
|
$
|
||||
|
Exchange of LLC Common Units
|
|
|
|
|
||||
|
Remeasurement – change in state rate
|
(
|
(
|
(
|
(
|
||||
|
Remeasurement – foreign tax credits
|
(
|
|
|
(
|
||||
|
Interest expense
|
|
|
|
|
||||
|
Payments
|
(
|
(
|
(
|
(
|
||||
|
Balance at December 31, 2024
|
$
|
$
|
$
|
$
|
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Gain on interest rate cap
|
$
(
|
$
(
|
$
(
|
|||
|
Gain on interest rate cap reclassified to earnings
|
|
|
|
|||
|
Foreign currency translation adjustments
|
|
(
|
|
|||
|
Change in share of equity method investment in related party
|
(
|
|
|
|||
|
Gain on
Interest Rate
Cap
|
Foreign
Currency
Translation
Adjustments
|
Change in EMI
Other
Comprehensive
Income (Loss)
1
|
Total
|
|||||
|
Balance at December 31, 2021
|
$
|
$
|
$
(
|
$
|
||||
|
Other comprehensive income (loss) before
reclassifications
|
|
(
|
(
|
|
||||
|
Amounts reclassified to earnings
|
(
|
|
|
(
|
||||
|
Other comprehensive income (loss)
|
$
|
$
(
|
$
(
|
$
|
||||
|
Less: Non-controlling interests
|
|
(
|
(
|
|
||||
|
Balance at December 31, 2022
|
$
|
$
|
$
(
|
$
|
||||
|
Other comprehensive income (loss) before
reclassifications
|
|
|
(
|
|
||||
|
Amounts reclassified to earnings
|
(
|
|
|
(
|
||||
|
Other comprehensive income (loss)
|
$
(
|
$
|
$
(
|
$
(
|
||||
|
Less: Non-controlling interests
|
(
|
|
(
|
(
|
||||
|
Balance at December 31, 2023
|
$
|
$
|
$
(
|
$
|
||||
|
Other comprehensive income (loss) before
reclassifications
|
|
(
|
|
|
||||
|
Amounts reclassified to earnings
|
(
|
|
|
(
|
||||
|
Other comprehensive income (loss)
|
$
(
|
$
(
|
$
|
$
(
|
||||
|
Less: Non-controlling interests
|
(
|
(
|
|
(
|
||||
|
Balance at December 31, 2024
|
$
|
$
(
|
$
(
|
$
(
|
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Net commissions and fees
|
$
|
$
|
$
|
|||
|
Fiduciary investment income
|
|
|
|
|||
|
Total revenue
|
$
|
$
|
$
|
|||
|
Compensation-related expense
1
|
|
|
|
|||
|
General and administrative expense
2
|
|
|
|
|||
|
Other segment items
3
|
|
|
|
|||
|
Depreciation and amortization
|
|
|
|
|||
|
Change in contingent consideration
|
(
|
|
|
|||
|
Interest income
|
(
|
(
|
(
|
|||
|
Interest expense
|
|
|
|
|||
|
Loss (income) from equity method investment in related party
|
(
|
(
|
|
|||
|
Income tax expense
|
|
|
|
|||
|
Other non-operating loss
|
|
|
|
|||
|
Net income
|
$
|
$
|
$
|
|||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
United States
|
$
|
$
|
$
|
|||
|
Foreign
|
|
|
|
|||
|
Total revenue
|
$
|
$
|
$
|
|||
|
Year Ended December 31,
|
||||||
|
2024
|
2023
|
2022
|
||||
|
Cash paid for:
|
||||||
|
Interest, net
1
|
$
|
$
|
$
|
|||
|
Income taxes, net of refunds
|
|
|
|
|||
|
Non-cash investing and financing activities:
|
||||||
|
Non-controlling interest holders’ tax distributions declared but
unpaid
|
$
|
$
|
$
|
|||
|
Tax Receivable Agreement liabilities
|
|
|
|
|||
|
Dividend Equivalents and Declared Distributions liabilities
|
|
|
|
|||
|
Contingently returnable consideration
|
|
|
|
|||
|
Contingent consideration liabilities
|
|
|
|
|||
|
Exhibit
Number
|
Description
|
||
|
3.1
|
|||
|
3.2
|
|||
|
3.3
|
|||
|
4.1
|
|||
|
4.2
|
|||
|
4.3
|
|||
|
4.4
|
|||
|
4.5
|
|||
|
4.6
|
|
||
|
4.7
|
|||
|
10.1
|
|||
|
10.2
|
|
||
|
10.3
|
+
|
|
|
|
10.4
|
+
|
||
|
10.5
|
|||
|
10.6
|
+
|
||
|
10.7
|
+
|
||
|
10.8
|
+
|
||
|
10.9
|
+
|
||
|
10.1
|
+
|
||
|
10.11
|
+
|
||
|
10.12
|
+
|
||
|
10.13
|
+
|
||
|
10.14
|
+
|
||
|
10.15
|
+
|
||
|
10.16
|
|
||
|
10.17
|
|
||
|
10.18
|
|
||
|
10.19
|
+
|
||
|
19.1
|
|||
|
21.1
|
|||
|
23.1
|
|||
|
31.1
|
|||
|
31.2
|
|||
|
32.1
|
*
|
||
|
32.2
|
*
|
||
|
97.1
|
|||
|
101.INS
|
Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does
not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL
document.
|
||
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
|
||
|
104
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
|
|
Date
February 20, 2025
|
|||
|
Ryan Specialty Holding, Inc
|
|||
|
By:
|
/s/ Timothy W. Turner
|
||
|
Timothy W. Turner, Chief Executive Officer
|
|||
|
Signature
|
Title
|
Date
|
|
/s/ Patrick G. Ryan
|
Executive Chairman and Chairman of the Board of Director
|
February 20, 2025
|
|
Patrick G. Ryan
|
||
|
/s/ Timothy W. Turner
|
Chief Executive Officer and Director (Principal Executive
Officer)
|
February 20, 2025
|
|
Timothy W. Turner
|
||
|
/s/ Janice M. Hamilton
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
|
February 20, 2025
|
|
Janice M. Hamilton
|
||
|
/s/ Henry S. Bienen
|
Director
|
February 20, 2025
|
|
Henry S. Bienen
|
||
|
/s/ David P. Bolger
|
Director
|
February 20, 2025
|
|
David P. Bolger
|
||
|
/s/ Michelle L. Collins
|
Director
|
February 20, 2025
|
|
Michelle L. Collins
|
||
|
/s/ Francesca Cornelli
|
Director
|
February 20, 2025
|
|
Francesca Cornelli
|
||
|
/s/ Nicholas D. Cortezi
|
Director
|
February 20, 2025
|
|
Nicholas D. Cortezi
|
||
|
/s/ D. Cameron Findlay
|
Director
|
February 20, 2025
|
|
D. Cameron Findlay
|
||
|
/s/ Anthony J. Kuczinski
|
Director
|
February 20, 2025
|
|
Anthony J. Kuczinski
|
||
|
/s/ Robert Le Blanc
|
Director
|
February 20, 2025
|
|
Robert Le Blanc
|
||
|
/s/ Michael D. O’Halleran
|
Director
|
February 20, 2025
|
|
Michael D. O’Halleran
|
||
|
/s/ John W. Rogers, Jr
|
Director
|
February 20, 2025
|
|
John W. Rogers, Jr
|
||
|
/s/ Patrick G. Ryan, Jr.
|
Director
|
February 20, 2025
|
|
Patrick G. Ryan, Jr.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|